STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

-0.27 (-0.34%)

Growth Price

Overvalued by 47.04%

Stability Price

Overvalued by 90.66%

Company Metrics

  • P/E 34.79
  • P/S 3.86
  • P/B 5.13
  • EPS 2.28
  • Cash ROIC 13.51%
  • Cash Ratio 0.27
  • Dividend 1.24 / 1.56%
  • Avg. Vol. 3.20M
  • Shares 289.94M
  • Market Cap. 23.01B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Hired experts back claims St. Jude heart devices can be hacked
Reuters - 6 hours ago
Short-selling firm Muddy Waters said in a legal filing on Monday that outside experts it hired validated its claims that St. Jude Medical Inc cardiac implants are vulnerable to potentially life-threatening cyber attacks. U.S. regulators responded by ...
Muddy Waters Fights St. Jude Over Pacemaker Reports - Bloomberg
St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical ...
Business Wire (press release) - 8 hours ago
BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today that it will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics ...
Short seller Muddy Waters renews claims of St. Jude Medical cyber vulnerabilities
MarketWatch - Oct 19, 2016
Short seller Muddy Waters Capital, which holds a short position in St. Jude Medical Inc., claimed Wednesday for the second time that the medical device maker's implantable cardiac devices are vulnerable to cyberattack.
Abbott, St. Jude Medical Plans to Sell $1.1 Billion in Assets After Deal Closes - Wall Street Journal
New cybersecurity allegations emerge as St. Jude Medical reports mixed ... - Minneapolis Star Tribune
Analysts Offer Predictions for St. Jude Medical Inc.'s Q1 2017 Earnings (STJ)
The Cerbat Gem - 6 hours ago
St. Jude Medical logo St. Jude Medical Inc. (NYSE:STJ) - Research analysts at SunTrust Banks cut their Q1 2017 EPS estimates for shares of St. Jude Medical in a note issued to investors on Wednesday.
St. Jude Medical Inc. (NYSE:STJ) Analyst Estimates And Rating - The Independent Republic
St. Jude Medical Warns of Battery Problems With Heart Products
Wall Street Journal - Oct 11, 2016
St. Jude Medical Inc. STJ -0.34 % warned Tuesday that a battery malfunction could cause hundreds of thousands of its implanted heart defibrillators to quickly lose power and stop functioning.
Two deaths spark recall of St. Jude heart devices - Reuters
Battery Problems in St. Jude Medical Defibrillators - WebMD
St. Jude Medical Inc. (STJ) Stock Rating Reaffirmed by Barclays PLC
The Cerbat Gem - Oct 22, 2016
St. Jude Medical logo St. Jude Medical Inc. (NYSE:STJ)'s stock had its “equal weight” rating restated by stock analysts at Barclays PLC in a report issued on Saturday.
St. Jude Medical, Inc. (NYSE:STJ) Files An 8-K - Market Exclusive
St. Jude Medical, Inc. Heart Device Recall
Legal Reader (blog) - Oct 14, 2016
St. Jude Medical, Inc. is a global company that designs and manufactures health management solutions, including heart devices.
Earnings Reaction History: St. Jude Medical, Inc., 44.4% Follow-Through ...
Nasdaq - Oct 19, 2016
St. Jude Medical, Inc. ( STJ ) is due to issue its quarterly earnings report in the upcoming extended-hours session.
Abbott, St. Jude Medical: Agreement Reached in Sale of Vascular Closure ... - Oct 20, 2016
Abbott Laboratories (NYSE:ABT) and St. Jude Medical Inc. (NYSE:STJ) agreed to sell St. Jude Medical's Angio-Seal and Femoseal, vascular closure products, and Abbott's Vado Steerable Sheath, a heart catheter, to Terumo Corp (TSE:4543) for a ...
Abbott, St. Jude Medical to Sell Assets (ABT, STJ) - Investopedia
St. Jude Medical, FDA and Top Pediatric Cardiology Experts Announce New ...
Business Wire (press release) - Oct 18, 2016
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the ADO II AS (AMPLATZER™ Duct Occluder II Additional Sizes) pediatric clinical trial.